4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015138
SVP OF CORP AFFAIRS & ADMIN. sold 20,853 shares at $33.73 ($703,334)
- SVP OF CORP AFFAIRS & ADMIN. acquired 20,853 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2024-05-30 | Option exercise | +10,750 | $2.78 | $29,885 | 12,610 | D |
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2024-05-30 | Option exercise | +10,103 | $9.02 | $91,094 | 22,713 | D |
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2024-05-30 | Sale | −20,853 | $33.73 | $703,334 | 1,860 | D |
| Derivatives | |||||||
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2024-05-30 | Option exercise · Incentive Stock Option (Right to Buy) | −10,750 | 0 | D | ||
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2024-05-30 | Option exercise · Incentive Stock Option (Right to Buy) | −10,103 | 0 | D | ||
| Open-market sales · 20,853 sh · avg $33.73 · $703,334 | |||||||
Loading xslF345X05/form4-06032024_080652.xml…